241 related articles for article (PubMed ID: 3913449)
1. Detoxification in hemosiderosis.
Simon P
Blood Purif; 1985; 3(1-3):75-88. PubMed ID: 3913449
[TBL] [Abstract][Full Text] [Related]
2. The chemistry of desferrioxamine chelation for aluminum overload in renal dialysis patients.
Day JP; Ackrill P
Ther Drug Monit; 1993 Dec; 15(6):598-601. PubMed ID: 8122301
[TBL] [Abstract][Full Text] [Related]
3. [Iron-overload in patients on maintenance hemodialysis: diagnostic criteria, indications and treatment by desferrioxamine (author's transl)].
Simon P; Bonn F; Guezennec M; Tanquerel T; Ksang
Nephrologie; 1981; 2(4):165-70. PubMed ID: 7329501
[TBL] [Abstract][Full Text] [Related]
4. Desferrioxamine in the treatment of aluminum overload.
Ackrill P; Day JP
Clin Nephrol; 1985; 24 Suppl 1():S94-7. PubMed ID: 3842106
[TBL] [Abstract][Full Text] [Related]
5. [Indications for desferrioxamine in patients with chronic renal insufficiency treated by dialysis].
Simon P
Nephrologie; 1986; 7(5):177-80. PubMed ID: 3822038
[No Abstract] [Full Text] [Related]
6. Desferrioxamine in the management of dialysis hemosiderosis.
Krumlovsky FA
Int J Artif Organs; 1982 Jul; 5(4):223-5. PubMed ID: 7118282
[No Abstract] [Full Text] [Related]
7. Iron overload in cardiac valvular disease and pure red cell aplasia: treatment with desferrioxamine.
Hehlmann R; Schmitz H; Krüger K
Int J Cardiol; 1984 Jun; 5(6):749-53. PubMed ID: 6235195
[TBL] [Abstract][Full Text] [Related]
8. Improvement of anaemia with desferrioxamine in haemodialysis patients.
Praga M; Andrés A; de la Serna J; Ruilope LM; Nieto J; Estenoz J; Millet VG; Arnaiz F; Rodicio JL
Nephrol Dial Transplant; 1987; 2(4):243-7. PubMed ID: 3118265
[TBL] [Abstract][Full Text] [Related]
9. Transfusional hemosiderosis and combined chelation therapy in sickle thalassemia.
Tsironi M; Polonifi K; Deftereos S; Farmakis D; Andriopoulos P; Moyssakis I; Aessopos A
Eur J Haematol; 2005 Oct; 75(4):355-8. PubMed ID: 16146544
[TBL] [Abstract][Full Text] [Related]
10. [Aluminum and iron deposition in dialysis patients].
Kurihara S; Marumo F
Nihon Rinsho; 1992 Jan; 50 Suppl():905-10. PubMed ID: 1578787
[No Abstract] [Full Text] [Related]
11. Iron overload, but not treatment with desferrioxamine favours the development of septicemia in patients on maintenance hemodialysis.
Seifert A; von Herrath D; Schaefer K
Q J Med; 1987 Dec; 65(248):1015-24. PubMed ID: 3455553
[TBL] [Abstract][Full Text] [Related]
12. Deferoxamine for the treatment of hemosiderosis during CAPD.
Gomez RA; Campbell F; Savory J; Chevalier RL
Int J Pediatr Nephrol; 1987; 8(1):21-4. PubMed ID: 3583552
[TBL] [Abstract][Full Text] [Related]
13. Clinical manifestations and therapy of transfusional haemosiderosis.
Gabutti V; Borgna-Pignatti C
Baillieres Clin Haematol; 1994 Dec; 7(4):919-40. PubMed ID: 7881160
[TBL] [Abstract][Full Text] [Related]
14. Treatment of iron overload in adults with continuous parenteral desferrioxamine.
Cooper B; Bunn HF; Propper RD; Nathan DG; Rosenthal DS; Moloney WC
Am J Med; 1977 Dec; 63(6):958-66. PubMed ID: 605917
[TBL] [Abstract][Full Text] [Related]
15. Mucormycosis--a new risk of deferoxamine therapy in dialysis patients with aluminum or iron overload?
Goodill JJ; Abuelo JG
N Engl J Med; 1987 Jul; 317(1):54. PubMed ID: 3587314
[No Abstract] [Full Text] [Related]
16. Therapy and monitoring of hypersiderosis in chronic renal insufficiency.
Hilfenhaus M; Koch KM; Bechstein PB; Schmidt H; Fassbinder W; Baldamus CA
Contrib Nephrol; 1984; 38():167-74. PubMed ID: 6713893
[TBL] [Abstract][Full Text] [Related]
17. Management of iron overload in dialysis patients.
Winchester JF
Semin Nephrol; 1986 Dec; 6(4 Suppl 1):22-6. PubMed ID: 3299589
[TBL] [Abstract][Full Text] [Related]
18. Diagnosis and treatment of iron overload in paediatric patients on chronic haemodialysis.
Eijgenraam FJ; Donckerwolcke RA; van Dijken PJ
Pediatr Nephrol; 1988 Jul; 2(3):303-8. PubMed ID: 3153030
[TBL] [Abstract][Full Text] [Related]
19. Methods for evaluating iron stores and efficacy of chelation in transfusional hemosiderosis.
Borgna-Pignatti C; Castriota-Scanderbeg A
Haematologica; 1991; 76(5):409-13. PubMed ID: 1806447
[TBL] [Abstract][Full Text] [Related]
20. Hemosiderosis in a dialysis patient: treatment with hemofiltration and deferoxamine chelation therapy.
McCarthy JT; Libertin CR; Mitchell JC; Fairbanks VF
Mayo Clin Proc; 1982 Jul; 57(7):439-41. PubMed ID: 7087549
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
